• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Merck

Merck

Merck & Co Inc MRK 4 Star

Last Price$58.98Day Change (%)2.34%
Open Price$58.59Day Change ($)1.35
Day Range58.09–58.9852-Week Range47.61–62.20

As of Thu 12/18/2014 04:46 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Acquisition of Cubist Pharmaceuticals, Inc. (CBST) by Merck & Co., Inc. (MRK ) May Not Be in Shareholders' Best Interests

    Acquisition of Cubist Pharmaceuticals, Inc. (CBST) by Merck & Co., Inc. ( MRK ) May Not Be in Shareholders' Best Interests

  2. Human trial of experimental Merck Ebola vaccine is suspended

    Human trial of experimental Merck Ebola vaccine is suspended

  3. CUBIST PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cubist Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Merck & Co. Inc. - CBST

    CUBIST PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cubist Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Merck & Co. Inc. - CBST

  4. Merck Acquires OncoEthix for Up to $375 Million

    Merck Acquires OncoEthix for Up to $375 Million

  5. Data Investigating KEYTRUDA® (pembrolizumab), Merck ’s Anti-PD-1 Therapy, in Patients with Classical Hodgkin Lymphoma Presented at ASH Annual Meeting

    Data Investigating KEYTRUDA® (pembrolizumab), Merck ’s Anti-PD-1 Therapy, in Patients with Classical Hodgkin Lymphoma Presented at ASH Annual Meeting

  6. UPDATE: Oracle, Microsoft, Sony climb; Dunkin' drops

    UPDATE: Oracle, Microsoft, Sony climb; Dunkin' drops

  7. Research and Markets: Human Papillomavirus Infections - Pipeline Review, H1 2014

    Research and Markets: Human Papillomavirus Infections - Pipeline Review, H1 2014

  8. Research and Markets: Mild Cognitive Impairment - Pipeline Review, H1 2014

    Research and Markets: Mild Cognitive Impairment - Pipeline Review, H1 2014

  9. Research and Markets: Pruritus - Pipeline Review, H1 2014

    Research and Markets: Pruritus - Pipeline Review, H1 2014

  10. Research and Markets: Post Menopausal Osteoporosis - Pipeline Review, H1 2014

    Research and Markets: Post Menopausal Osteoporosis - Pipeline Review, H1 2014

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.